AnaptysBio Overview
AnaptysBio Target Price
See AnaptysBio's analyst price targets ($81) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$47.77
Average Target Price
$81.00
69.6% upside
69.6% upside4 analysts in the last 4 months
High: $95 | Low: $70
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-23 | Leerink Partners | $81 | 69.6% upside |  |
| 2026-09-22 | H.C. WainwrightJoseph Pantginis | $95 | 98.9% upside | |
| 2026-08-31 | Wolfe ResearchAndy Chen | $78 | 63.3% upside | |
| 2026-08-25 | Scotiabank | $70 | 46.5% upside | |
| 2026-05-15 | Leerink Partners | $90 | 88.4% upside | |
| 2026-05-13 | UBS | $76 | 59.1% upside | |
| 2026-05-13 | Barclays | $75 | 57% upside | |
| 2026-04-28 | Leerink Partners | $85 | 77.9% upside | |
| 2026-04-21 | UBS | $60 | 25.6% upside | |
| 2026-03-06 | Truist FinancialJohn Lee | $50 | 4.7% upside | |
| 2026-03-05 | Stifel NicolausAlex Thompson | $85 | 77.9% upside | |
| 2026-03-04 | H.C. WainwrightEmily Bodnar | $66 | 38.2% upside | |
| 2026-01-07 | UBSMichael Yee | $70 | 46.5% upside | |
| 2025-12-18 | Guggenheim | $140 | 193.1% upside | |
| 2025-12-17 | BarclaysEtzer Darout | $55 | 15.1% upside | |
| 2025-12-11 | Stifel Nicolaus | $56 | 17.2% upside | |
| 2025-11-11 | Barclays | $70 | 46.5% upside | |
| 2025-11-10 | WedbushDavid Nierengarten | $50 | 4.7% upside | |
| 2025-11-10 | Truist FinancialJoon Lee | $36 |  24.6% downside | |
| 2025-10-29 | Stifel Nicolaus | $80 | 67.5% upside | |
| 2025-10-15 | WedbushDavid Nierengarten | $70 | 46.5% upside | |
| 2025-10-13 | Barclays | $78 | 63.3% upside | |
| 2025-09-30 | H.C. Wainwright | $59 | 23.5% upside | |
| 2025-05-06 | GuggenheimYatin Suneja | $54 | 13% upside | |
| 2025-03-03 | Guggenheim | $52 | 8.9% upside | |
| 2025-02-04 | Wolfe ResearchAndy Chen | $25 | 47.7% downside | |
| 2024-12-11 | H.C. WainwrightEmily Bodnar | $19 | 60.2% downside | |
| 2024-11-06 | H.C. WainwrightEmily Bodnar | $52 | 8.9% upside | |
| 2024-11-06 | Leerink PartnersDavid Risinger | $45 | 5.8% downside | |
| 2024-10-21 | GuggenheimYatin Suneja | $90 | 88.4% upside | |
| 2024-10-15 | Piper SandlerYasmeen Rahimi | $80 | 67.5% upside | |
| 2024-10-03 | New StreetDavid Risinger | $35 | 26.7% downside | |
| 2024-08-15 | Truist FinancialJoon Lee | $30 | 37.2% downside | |
| 2024-04-16 | Leerink PartnersDavid Risinger | $47 | 1.6% downside | |
| 2022-11-18 | J.P. Morgan | $32 | 33% downside | |